development of symptoms were associated with a further , preferential loss of leu 8+ cd4 cells , proportional losses of both cd4 subsets defined by leu 18 expression , and a return to normal levels of leu 7- cd8 , leu 17- cd8 , and hla-dr- cd8 cells .
C0039215
cd4 cells
C0019764
hla-dr